CO5700712A2 - Prevencion y tratamiento de la enfermedad de alzheimer - Google Patents
Prevencion y tratamiento de la enfermedad de alzheimerInfo
- Publication number
- CO5700712A2 CO5700712A2 CO05056010A CO05056010A CO5700712A2 CO 5700712 A2 CO5700712 A2 CO 5700712A2 CO 05056010 A CO05056010 A CO 05056010A CO 05056010 A CO05056010 A CO 05056010A CO 5700712 A2 CO5700712 A2 CO 5700712A2
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- propyl
- butyl
- ethyl
- bile acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Abstract
1.- Aplicación de compuestos inhibidores de recaptura de ácidos biliares para la preparación de un medicamento que permita prevenir o tratar la enfermedad de Alzheimer.2.- Aplicación según la reivindicación 1, caracterizada porque los inhibidores de recaptura de ácidos biliares son compuestos de fórmula (lA):en la cual:R1 representa metilo, etilo, propilo o butilo;R2 representa H, OH, NH2 o NH-alquilo C1-C6;R3 es un monosacárido, bisacárido, trisacárido o tetrasacárido, en que dicho radical está sin sustituir o mono- o poli-sustituido con un grupo protector de azúcares;R4 es metilo, etilo, propilo o butilo;R5 es metilo, etilo, propilo o butilo;Z es (C=O)n-alquilo (C0-C16); (C=O)n-alquilo (CO-C16)-NH; (C=O)n-alquilo (C0-C16)-O; (C=O)n-alquilo (C0-C16)-(C=O)- o un enlace covalente;n es 0 ó 1;m es 0 ó 1;así como sus sales por adiciones farmacéuticamente aceptables.3.- Aplicación según la reivindicación 1 ó 2, caracterizada porque el inhibidor de recaptura de ácidos biliares es el compuesto de fórmula (lA) siguiente:
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0215722A FR2848452B1 (fr) | 2002-12-12 | 2002-12-12 | Application des inhibiteurs de recapture intestinale des acides biliaires pour la prevention et le traitement de la maladie d'alzheimer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5700712A2 true CO5700712A2 (es) | 2006-11-30 |
Family
ID=32338722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO05056010A CO5700712A2 (es) | 2002-12-12 | 2005-06-09 | Prevencion y tratamiento de la enfermedad de alzheimer |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1572174A1 (es) |
| JP (1) | JP2006514063A (es) |
| KR (1) | KR20050084250A (es) |
| CN (1) | CN1726016A (es) |
| AR (1) | AR042354A1 (es) |
| AU (1) | AU2003296802A1 (es) |
| BR (1) | BR0317280A (es) |
| CA (1) | CA2507945A1 (es) |
| CO (1) | CO5700712A2 (es) |
| FR (1) | FR2848452B1 (es) |
| HR (1) | HRP20050534A2 (es) |
| MA (1) | MA27500A1 (es) |
| MX (1) | MXPA05005556A (es) |
| NO (1) | NO20053341L (es) |
| NZ (1) | NZ540496A (es) |
| PE (1) | PE20040770A1 (es) |
| PL (1) | PL377110A1 (es) |
| RS (1) | RS20050420A (es) |
| RU (1) | RU2005121909A (es) |
| TW (1) | TW200503707A (es) |
| WO (1) | WO2004062652A1 (es) |
| ZA (1) | ZA200504656B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7521481B2 (en) | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
| AU2004290499C1 (en) | 2003-11-03 | 2011-02-24 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
| CA2554809C (en) | 2004-02-05 | 2014-04-29 | Probiodrug Ag | Novel n-alkyl thiourea- and thioamide-substituted imidazolyl inhibitors of glutaminyl cyclase |
| CA2589102C (en) | 2004-11-02 | 2013-08-13 | Northwestern University | Pyridazine compounds and methods for using the compounds to treat inflammatory diseases |
| EP2015750A2 (en) | 2006-04-28 | 2009-01-21 | Northwestern University | Compositions and treatments using pyridazine compounds and cholinesterase inhibitors |
| MX2009012583A (es) * | 2007-05-22 | 2010-03-08 | Otsuka Pharma Co Ltd | Un medicamento que comprende un derivado de carbostirilo y donepezilo para tratar enfermedad de alzheimer. |
| US20140243281A1 (en) * | 2011-10-28 | 2014-08-28 | Lumena Pharmaceuticals, Inc. | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases |
| EP2770990A4 (en) | 2011-10-28 | 2015-03-11 | Lumena Pharmaceuticals Inc | Gallic acid refluxing agent for the treatment of hypertension and chronic liver disease |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2040996A1 (en) * | 1990-05-02 | 1991-11-03 | Robert L. Albright | Composition and method for controlling cholesterol |
| ATE231723T1 (de) * | 1991-02-22 | 2003-02-15 | Howard K Shapiro | Verwendung von pharmazeutischen wirkstoffen zur behandlung von krankheitssymptomen neurologischer erkrankungen und etiologisch verwandter symptomenkomplexe |
| WO1997049736A2 (en) * | 1996-06-27 | 1997-12-31 | G.D. Searle And Co. | Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| US5985936A (en) * | 1997-12-18 | 1999-11-16 | Forbes Medi-Tech, Inc. | Method of preventing and delaying onset of Alzheimer's disease and composition therefor |
| CA2311356C (en) * | 1998-01-28 | 2004-07-13 | Warner-Lambert Company | Method for treating alzheimer's disease |
| US6080778A (en) * | 1998-03-23 | 2000-06-27 | Children's Medical Center Corporation | Methods for decreasing beta amyloid protein |
| US6221897B1 (en) * | 1998-06-10 | 2001-04-24 | Aventis Pharma Deutschland Gmbh | Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use |
| DE19825804C2 (de) * | 1998-06-10 | 2000-08-24 | Aventis Pharma Gmbh | 1,4-Benzothiepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DE19845405C2 (de) * | 1998-10-02 | 2000-07-13 | Aventis Pharma Gmbh | Arylsubstituierte Propanolaminderivate und deren Verwendung |
| AU2001233299A1 (en) * | 2000-02-04 | 2001-08-14 | Esperion Therapeutics Inc. | Methods for treating alzheimer's disease |
| US20020028826A1 (en) * | 2000-06-15 | 2002-03-07 | Robl Jeffrey A. | HMG-CoA reductase inhibitors and method |
| SE0104334D0 (sv) * | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
| TWI329111B (en) * | 2002-05-24 | 2010-08-21 | X Ceptor Therapeutics Inc | Azepinoindole and pyridoindole derivatives as pharmaceutical agents |
-
2002
- 2002-12-12 FR FR0215722A patent/FR2848452B1/fr not_active Expired - Fee Related
-
2003
- 2003-12-10 KR KR1020057010595A patent/KR20050084250A/ko not_active Application Discontinuation
- 2003-12-10 RU RU2005121909/15A patent/RU2005121909A/ru not_active Application Discontinuation
- 2003-12-10 WO PCT/FR2003/003654 patent/WO2004062652A1/fr active Application Filing
- 2003-12-10 NZ NZ540496A patent/NZ540496A/en unknown
- 2003-12-10 AR ARP030104540A patent/AR042354A1/es not_active Application Discontinuation
- 2003-12-10 CA CA002507945A patent/CA2507945A1/fr not_active Abandoned
- 2003-12-10 PL PL377110A patent/PL377110A1/pl not_active Application Discontinuation
- 2003-12-10 JP JP2004566119A patent/JP2006514063A/ja not_active Abandoned
- 2003-12-10 AU AU2003296802A patent/AU2003296802A1/en not_active Abandoned
- 2003-12-10 EP EP03815109A patent/EP1572174A1/fr not_active Withdrawn
- 2003-12-10 CN CNA2003801059727A patent/CN1726016A/zh active Pending
- 2003-12-10 BR BR0317280-5A patent/BR0317280A/pt not_active IP Right Cessation
- 2003-12-10 RS YUP-2005/0420A patent/RS20050420A/sr unknown
- 2003-12-10 PE PE2003001247A patent/PE20040770A1/es not_active Application Discontinuation
- 2003-12-10 MX MXPA05005556A patent/MXPA05005556A/es not_active Application Discontinuation
- 2003-12-11 TW TW092134949A patent/TW200503707A/zh unknown
-
2005
- 2005-06-07 ZA ZA200504656A patent/ZA200504656B/en unknown
- 2005-06-09 CO CO05056010A patent/CO5700712A2/es not_active Application Discontinuation
- 2005-06-10 MA MA28329A patent/MA27500A1/fr unknown
- 2005-06-10 HR HR20050534A patent/HRP20050534A2/xx not_active Application Discontinuation
- 2005-07-08 NO NO20053341A patent/NO20053341L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004062652A1 (fr) | 2004-07-29 |
| BR0317280A (pt) | 2005-11-08 |
| PL377110A1 (pl) | 2006-01-23 |
| AR042354A1 (es) | 2005-06-15 |
| AU2003296802A1 (en) | 2004-08-10 |
| MXPA05005556A (es) | 2005-07-26 |
| PE20040770A1 (es) | 2004-12-10 |
| MA27500A1 (fr) | 2005-08-01 |
| ZA200504656B (en) | 2006-08-30 |
| NO20053341L (no) | 2005-09-07 |
| RS20050420A (en) | 2007-04-10 |
| RU2005121909A (ru) | 2006-01-20 |
| JP2006514063A (ja) | 2006-04-27 |
| CN1726016A (zh) | 2006-01-25 |
| TW200503707A (en) | 2005-02-01 |
| FR2848452A1 (fr) | 2004-06-18 |
| EP1572174A1 (fr) | 2005-09-14 |
| CA2507945A1 (fr) | 2004-07-29 |
| NO20053341D0 (no) | 2005-07-08 |
| FR2848452B1 (fr) | 2007-04-06 |
| HRP20050534A2 (en) | 2006-11-30 |
| KR20050084250A (ko) | 2005-08-26 |
| NZ540496A (en) | 2008-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0312999A (pt) | Compostos, composições farmacêticas, método para aumentar a cognição, de tratamento, de inibição da atividade de enzima pde4 em um paciente | |
| UY28674A1 (es) | Inhibidores heterociclil amino de 11-beta-hidroxiesteroide deshidrogenasa tipo 1 | |
| BR0010555A (pt) | Inibidores de neuraminidases | |
| HUP0301427A2 (hu) | Fotokemoterápiában alkalmazható fotoszenzitizáló, 5-aminolevulinsavészterek azokat tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| TW200420549A (en) | Thiazole derivatives | |
| CO5611108A2 (es) | Benzazoles sustituidos y su aplicacion como inhibidores quinasa raf | |
| NZ580226A (en) | Dimer compounds as inhibitors of iap | |
| ECSP045004A (es) | Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades andrógeno dependientes | |
| WO2008002573A3 (en) | Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated deseases or conditions | |
| BRPI0409624A (pt) | 2-hidróxi-3-diaminoalcanos de benzamida | |
| CO6241190A2 (es) | Compuestos para inhibicion enzimatica | |
| PE20020276A1 (es) | COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER | |
| DE60130023D1 (de) | Behandlung der nebenwirkungen von statinen | |
| MX2009008779A (es) | Composicion farmacéutica que comprende derivado de pirazina y método para usar el derivado de pirazina en combinación. | |
| PH12023550160A1 (en) | Combinations for the Treatment of Cancer | |
| EP2639229A3 (en) | Thiazole Derivative and use thereof as VAP-1 Inhibitor | |
| TWI265929B (en) | Triazinyl derivatives for inhibiting the production of IL-12 | |
| TW200510311A (en) | CCr8 inhibitors | |
| ATE427941T1 (de) | Thiazolderivate mit vap-1-hemmender wirkung | |
| WO2006028269A3 (en) | Thiazole derivatives having vap-1 ihibitory activity | |
| CO5700712A2 (es) | Prevencion y tratamiento de la enfermedad de alzheimer | |
| GEP20125548B (en) | New dihidroindolone compounds, a process for its preparation and pharmaceutical compositions containing them | |
| HK1127476A1 (en) | Pyrazolopyrimidine derivative | |
| TW200745048A (en) | Novel benzimidazole and benzothiazole derivatives, preparation process therefor, application thereof as medicaments, pharmaceutical compositions and novel use especially as CMET inhibitors | |
| AR035285A1 (es) | Formulaciones en combinacion de derivados de1,4-benzotiepina-1,1-dioxido con otras sustancias activas, y su utilizacion. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |